Yue Kang, speaking at Late Phase Drug Development World Europe 2011

Yue Kang,
Head of Clinical Development
Abbott

Yue KANG, M.D., M.Sc, Affiliate Medical Director, Abbott Laboratories China, since 2008. Responsible for the medical department performance, including clinical research (ph 1~4); medical affairs; drug safety, medical information, medical operation, and compliance. Before 2008, Yue was Head of Medical Affairs of Boehringer Ingelheim (BI) China and BI Asia regional medical advisor with the company. Yue has more than 12-year pharma industry experience from China market. Yue got his master degree of neuropathology from Shanghai Medical University 1998, and got bachelor degree of clinical medicine from Shanghai Medical University 1994.

Appearing:

Day Two- Thursday 8th December 2011

2.30pm

Late phase drug development in China

• China regulatory environment for late phase development
• Late phase study concept validation and process management
• Translate study result into real practice and policy formation

Yue Kang,

Head of Clinical Development,
Abbott

Sponsor Late Phase Drug Development World Europe 2011 ›

Premium sponsor